Tennessee (State or Other Jurisdiction of Incorporation) |
001-15875 (Commission File Number) |
54-1684963 (I.R.S. Employer Identification No.) |
||
501 Fifth Street | 37620 | |||
Bristol, Tennessee | (Zip Code) | |||
(Address of principal executive offices) |
o | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.01. Completion of Acquisition or Disposition of Assets | ||||||||
Item 9.01. Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EX-23.1 | ||||||||
EX-99.1 | ||||||||
EX-99.2 | ||||||||
EX-99.3 |
1. | Alpharmas audited consolidated financial statements as of December 31, 2007 and 2006 and for each of the three years ended December 31, 2007, 2006, and 2005 are attached as Exhibit 99.1 and are incorporated herein by reference. | ||
2. | Alpharmas condensed consolidated financial statements as of September 30, 2008, and for the three and nine months ended September 30, 2008 and 2007, are attached as Exhibit 99.2 and are incorporated herein by reference. |
Exhibit No. | Description | |
23.1
|
Consent of Independent Registered Public Accounting Firm. | |
99.1
|
Audited consolidated financial statements of Alpharma, Inc. as of December 31, 2007 and 2006 and for each of the three years ended December 31, 2007, 2006 and 2005. | |
99.2
|
Unaudited condensed consolidated financial statements of Alpharma, Inc. as of September 30, 2008, and for the three and nine months ended September 30, 2008 and 2007. | |
99.3
|
Unaudited pro forma financial information for the twelve months ended December 31, 2007 and for the nine months ended September 30, 2008. |
KING PHARMACEUTICALS, INC. |
||||
By: | /s/ Joseph Squicciarino | |||
Name: | Joseph Squicciarino | |||
Title: | Chief Financial Officer | |||